U.S. Markets closed

OncoGenex Pharmaceuticals (OGXI) Soars: Stock Up 6.8%

Zacks Equity Research

OncoGenex Pharmaceuticals, Inc. (OGXI) was a big mover last session, as its shares rose nearly 7% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company as the stock is now trading above the volatile price range of $10.66 to $12.09 in the past one-month time frame.

In the last 30-day frame, the company has not seen any estimate revision and the Zacks Consensus Estimate also remained unchanged. However, yesterday’s price action is encouraging, so make sure to keep a close watch on this firm in the near future.

OncoGenex currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked medical stocks include BioLineRx, Ltd. (BLRX), BioSpecifics Technologies Corp. (BSTC) and Cardiome Pharma Corp. (CRME). All three carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


BIOLINERX LTD ADS (BLRX): Free Stock Analysis Report

CARDIOME PHARMA CORP ORD (CRME): Free Stock Analysis Report

BIOSPECIFICS TECH CORP (BSTC): Free Stock Analysis Report

Zacks Investment Research